Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...
Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weightloss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in ...